These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15089783)

  • 1. Prevention of Type 2 diabetes mellitus. A review of the evidence and its application in a UK setting.
    Davies MJ; Tringham JR; Troughton J; Khunti KK
    Diabet Med; 2004 May; 21(5):403-14. PubMed ID: 15089783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
    Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
    Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2010; 16(34):3939-847. PubMed ID: 21128892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment for patients with impaired glucose tolerance].
    Tawaramoto K; Kaku K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of type 2 diabetes mellitus].
    Lyra R; Oliveira M; Lins D; Cavalcanti N
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):239-49. PubMed ID: 16767290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes?
    Swanson A; Watrin K; Wilder L
    J Fam Pract; 2010 Sep; 59(9):532-3. PubMed ID: 20824232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions in the prevention of type 2 diabetes.
    Henness S
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.
    Holman RR; Bethel MA; Chan JC; Chiasson JL; Doran Z; Ge J; Gerstein H; Huo Y; McMurray JJ; Ryden L; Liyanage W; Schröder S; Tendera M; Theodorakis MJ; Tuomilehto J; Yang W; Hu D; Pan C;
    Am Heart J; 2014 Jul; 168(1):23-9.e2. PubMed ID: 24952856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can type 2 diabetes mellitus be considered preventable?
    Jermendy G
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S73-81. PubMed ID: 15955380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of success of a lifestyle intervention in relation to weight loss and improvement in glucose tolerance among individuals at high risk for type 2 diabetes: the FIN-D2D project.
    Rautio N; Jokelainen J; Saaristo T; Oksa H; Keinänen-Kiukaanniemi S; ; Peltonen M; Vanhala M; Korpi-Hyövälti E; Moilanen L; Saltevo J; Niskanen L; Tuomilehto J; Uusitupa M
    J Prim Care Community Health; 2013 Jan; 4(1):59-66. PubMed ID: 23799691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of type 2 diabetes--an overview].
    Qvigstad E
    Tidsskr Nor Laegeforen; 2004 Dec; 124(23):3047-50. PubMed ID: 15586184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of type 2 diabetes in the prediabetic population.
    Maji D; Roy RU; Das S
    J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes prevention program (metformin)].
    Kusaka I; Nagasaka S
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():471-7. PubMed ID: 15779424
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes prevention: is there more to it than lifestyle changes?
    Gruber A; Nasser K; Smith R; Sharma JC; Thomson GA
    Int J Clin Pract; 2006 May; 60(5):590-4. PubMed ID: 16700860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Info-Meeting. Pharmacologic prevention of the progression from impaired glucose tolerance to type 2 diabetes: favorable effects of metformin and acarbose].
    Scheen AJ
    Rev Med Liege; 2001 Oct; 56(10):727-30. PubMed ID: 11765586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Impaired Glucose Tolerance (Prediabetes) and Prevention of Type 2 Diabetes.
    Abdallah MA; Ahmed KM; Stevens D; Griebeler M
    S D Med; 2019 Feb; 72(2):67-73. PubMed ID: 30855734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of type 2 diabetes.
    Lai LC
    Malays J Pathol; 2002 Dec; 24(2):71-6. PubMed ID: 12887163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.
    Zinman B; Harris SB; Gerstein HC; Young TK; Raboud JM; Neuman J; Hanley AJ
    Diabetes Obes Metab; 2006 Sep; 8(5):531-7. PubMed ID: 16918588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.